Uyang Syntech Ninfan Co Ltd

Company Overview

Uyang Syntech Ninfan Co Ltd provides leading healthcare services in: Research

& Development; Manufacturing; Distribution; and, Retail. SPH has developed and

delivered healthcare solutions and effective medicines to patients in India

,China, USA, Australia, Canada, EU and worldwide for the past century. SPH is

committed to continuously bringing innovative medicines to patients that

alleviate or cure diseases.mission is to work with researchers, collaborators,

and investors to identify and advance biopharmaceutical innovations

that address unmet medical needs.

The last few years have seen dramatic growth in outsourcing to India in all

areas of technology. The trend has been particularly noticeable in the

pharmaceuticals sector. Leading pharmaceutical firms across the world are

increasingly turning to India to outsource processes and solutions as part of

their efforts to bring down the price of drugs. Drug makers operating in US

could save at least 60 per cent in producing new drugs by outsourcing R&D and

other services to India; it is estimated. In this way, we come in to picture.

Uyang Syntech Ninfan Co Ltd is pharma house which offers third-party

manufacturing for domestic and export formulations with optimum quality at

most competitive rates with excellent backup team to ensure on Schedule

delivery.Pharmaceutical intermediates,

animal medecines,

Animal sedatives,

pharmaceutical-machinery,

pill-press-machines,

animal veterinary ,

Protonitazene (hydrochloride),

Cas 71368-80-4 Bromazolam

Cas 2647-50-9 Flubromazepam

Sea food,

Animal plants medecine,

Uyang Syntech Ninfan Co Ltd are in to Contract – Manufacturing of Tablets,

Capsules, Injectables, Ointments, Generics, Drops Eye / Ears, Creams,

Shampoos, Cosmetics, Herbal Preparations, Hard Gelatine, Soft Gelatine, Dry

Syrup, Lotions, Protein Supplements,intermediates, raw chemicals powders,

phamaceutical intermediates, pharmaceutical precursors, Powders, Dietary

supplement, Soaps, Formulations & Contract Manufacturing. and are going from

strength, since 5 years of commitment and sound knowledge of good Contract –

manufacturing practices.

Quality Control

Products falling in to controlled substance category / list of schedule drugs

shall be exported directly from the manufacturer principals only against

receipt of original import permission issued by concerned authorities of the

importing country. Products protected by valid patents are not offered for

sale in countries where the sale of such products constitutes a patent

infringement and its liability is at buyer’s risk. Most OTC drugs are not

reviewed and approved by FDA, however, they may be marketed if they comply

with applicable regulations and policies. FDA has not evaluated whether this

product complies. This is only for study not for any Human / Veterinary use.

(Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers

not to use/sell/procure any goods to achieve a product which might be

knowingly causing an infringement / controlled / banned drugs. Delphis

Pharmaceutical India is not responsible or liable for the same.

Code of Conduct